Rhesus monkeys were obtained from Mr. Anand of New Delhi, India, and the vervets from Shamrock Farms, Upper Horton Farm, Small Dole, Henfield, Sussex.
The country of origin of these vervet monkeys is not known, but they were shipped to England from Keny.'.
Routes of inoculation and doses of inoculum
Guinea-pigs were inoculated intraperitoneally with 0.1 ml of inoculum (for preparation of inoculum, see below). Monkeys were inoculated intraperitoneally with 0.2 ml or 0.5 m!, subcutaneously with 0.2 m!, or intracerebralIy with 0.15 m!.
Procedures
Monkeys were sedated with intramuscular phencyclidine (3-4 mg) and bled from the femoral vein before inoculation.
They were then given either:
(a) whole heparinised infective guinea-pig blood, or (b) whole heparinised infective monkey blood, or (c) various dilutions of infective rhesus monkey liver suspensions.
The actual dose was calculated by parallel intraperitoneal titration in guinea-pIgs.
Lightly heparinised (10 iu heparin per I ml blood) blood samples were colIected daily under phencyclidine sedation by femoral venepuncture and inoculated into guinea-pigs to detect circulating agent. Rectal temperatures were recorded daily for each monkey.
During the febrile stages of ilIness, rectal and throat swabs were also taken, eluted in pH 7.2 phosphate buffered saline and inoculated into guinea-pigs.
Urine samples were collected by syringe and needle at necropsy and similarly tested.
A few monkeys died as a result of the illness, but the majority were bled and then killed with intracardiac nembutal.
Brain, liver, lung, spleen and kidney were removed and 10 per cent suspensions of each prepared by emulsifying in pH 7.2 phosphate buffered saline containing 0.75 per cent bovine plasma albumin (Armour Fraction V). The suspensions were then inoculated into guinea-pigs.
Monkey sera
The sera came from 201 vervet monkeys, most of which were caught in Uganda at about the same time as the monkeys responsible for the disease in Germany and Yugoslavia.
Serum from one of the two langur monkeys which were in contact at London with the German batches of monkeys was also tested.
Complement-fixation tests
Tests were carried out either by the standard method of the Public Health Laboratory Service (Bradstreet & Taylor, 1962) , but using MRe lucite plates with 3 units of complement and a final erythrocyte concentration of 2 per cent, or else by the micro-technique described by Sever (I962), using a final erythrocyte concentration of 0.4 per cent.
Antigens used: a centrifuged suspension of infected guinea-pig spleen in physiological saline solution treated with 2 per cent chloroform and 1/10 000 merthiolate as a preservative; a 20 per cent suspension of infected guinea-pig liver or spleen, or vervet monkey liver, emulsified in 0.5 per cent formol saline in a pH 7.2 phosphate buffered saline. Suspensions were held at 4°e for 48 hours and then centrifuged in an angle-head refrigerated centifuge at 10 000 r.p.m. for 30 minutes.
The deposit was resuspended and shaken with an equal volume of ether, and then stored overnight at 4°C. This was recentrifuged, the deposit again extracted with ether, and the process repeated a further three times.
The final deposit was resuspended in 1/15 of its original volume in 0.25 per cent formol saline in phosphate buffer at pH 7.2.
Treatment of sera
Initial tests indicated that a large number of the monkey sera were anticomplementary.
They were treated by addition of an equal volume of guineapig complement, storage at 4°e overnight, and then incubated in a 37°e water bath for 30 minutes.
The serum mixture was then diluted 1 in 5 and inactivated in a 56°e or 60 0 e water bath for 30 minutes. It was then stored at -20 o e until tested.
Safety precautions
All potentially infected material was handled in efficient and carefully tested safety cabinets.
Where this was not possible, as when inoculating and bleeding monkeys, the personnel wore protective clothing, surgical gloves and biological respirators.
All animal experiments were carried out in rooms from which the extracted air was individually filtered, and all effluent was sterilised.
Irrespective of the route of inoculation or the dose of the inocula, all infected monkeys, whether rhesus or vervet, developed a febrile illness after incubation periods varying from 2-6 days. The febrile illness (see Table I ) continued until immediately prior to death, when a fall in temperature was often recorded. Generally no overt signs of illness were noted in any of the monkeys before or during the first few days of the febrile stage. Loss of weight, however, was noted in a few monkeys. It was generally only one or, rarely, two days before the animals either became moribund or died that signs of illness were apparent. The monkeys then did not eat or drink, sat huddled up in their cages and failed to respond to provocation.
In a few animals. and in particular in the two rhesus monkeys inoculated intraperitoneally, a petechial skin rash was observed-particularly on the flexor surfaces of the arms and thighs, and to a lesser extent on the face, neck and upper thorax-on the last day of illness. In addition, blood taken from several moribund animals failed to clot. One monkey was found to have tarry stools on two days prior to death.
RESULTS
The Table shows that the infective agent was present in the blood during the febrile period of the illness, and it could generally be detected in the blood before the animals became febrile, but its appearance was delayed with lower dosages. The incubation period was also longer following subcutaneous than intraperitoneal inoculation, even with high doses.
Throat swabs and rectal swabs were collected only from rhesus monkeys CI, C2 and C3 on the 4th and 6th days after infection. The infectious agent was detected only in the saliva of monkey Cion the 4th day but was present in the saliva of all three on the 6th day. The agent was recovered only from the rectal swab of monkey Cion Day 6, but blood was present in its stools at this time and probably accounted for the presence of the agent. Urine was collected from monkey CI and C2 immediately after they were killed: both samples were found to contain appreciable amounts of the agent.
Organs from vervet monkeys BI, B2, B3 and B5 and rhesus AlO were also tested for the presence of the infective agent: it was recovered from brain, liver, spleen and lung of all of them.
One other vervet monkey present in the same room but not immediately in contact with infected monkeys died 7 days after 2 monkeys had been autopsied in the room, and was found histologically to have similar lesions to those in infected monkeys. 
Serological results
No complement-fixing antibodies were detected in any of the 201 wildcaught monkey sera tested. Anticomplementary effects were very common but were considerably reduced by the method described. The serum of the langur monkey was also negative. DISCUSSION Saenz (1967) gave a brief account of how the German laboratory workers became infected. Only those workers who were in contact with blood and tissues removed from vervet monkeys or with blood or tissues of patients became infected. Animal attendants who fed or watered the monkeys escaped infection.
The studies reported here indicate that monkeys with considerable amounts of the infectious agent circulating in their blood can appear quite healthy for several days. However, all infected monkeys developed a fatal illness eventually. One of the monkeys used in Germany may therefore have appeared healthy but have been highly infective at the time that its kidneys were removed. However the incubation periods we have so far demonstrated have been rather too short to account for the occurrences, even though the quarantine period in Germany was very brief. There were, however, some deaths in the monkeys soon after arrival in Germany and Yugoslavia and one or more of these may have been due to the disease. Such a monkey may have infected others in the batch and these may have been in the early stages of disease when used in the laboratory. The incubation period following natural infection may be longer as guinea-pig passage may have increased the virulence of the agent for monkeys. The saliva and urine of infected monkeys have also been shown to be infectious and could possibly lead to infection of other monkeys or laboratory workers. The fact that one uninoculated monkey died after being housed in the same room as infected monkeys, but not in direct contact with them, indicates that infection may be transmitted by aerosol, possibly generated by urination. These findings further emphasise the need for carefully designed procedures for quarantine and handling of monkeys and their tissues.
The epidemiology of the disease remains a mystery. The absence of antibodies to the agent in monkeys caught in the same area is not surprising as the infection must be a rare one in view of the large number of vervets previously used without incident. Moreover, the absence of evidence of infection in the langur monkey does not exclude the possibility that crossinfection from some other species may have occurred at Heathrow Airport. The chances of now tracing this infection to its source are not good, but it would be very unwise to assume that the incident will not recur and suitable precautions must now be obligatory on all who handle monkeys and their tissues-or indeed those of other recently-trapped wild species.
